Topics
November/December 2016 | Special Focus: The Year In Review
Recapping the Past 12 Months
the staff of Retina Today
November/December 2015 | Special Focus: The Year In Review
In the Rearview: Highlights of Happenings From 2015
A brief look at significant events, innovative products, and other notable headlines from the past year.
From the staff of Retina Today
April 17, 2026
Phase 1 Data for Vamikibart Published in JAMA Ophthalmology
MeiraGTx Announces the Acquisition of XLRP Therapy From J&J
April 16, 2026
Experimental Light-Activated Therapy Shows Early Promise for Retinitis Pigmentosa
April 15, 2026
Curative Biotechnology Engages Sterling Pharmaceutical Services to Manufacture Clinical Supply for Ophthalmic Program
April 2026 Insert
Editorially independent supported by Abbvie and Regenxbio
April 2026 Supplement
Editorially independent content supported with advertising by EyePoint
Free Print Subscription
Email Newsletter
Conference Calendar
